Three Liquid-Liquid Phase Separation-Related Genes Associated with Prognosis in Glioma

References

• Peng Q, Wang L, Qin Z, et al. Phase Separation of Epstein-Barr Virus EBNA2 and Its Coactivator EBNALP Controls Gene Expression. J Virol. 2020;94(7). doi:10.1128/JVI.01771-19
   Web of Science ®Google Scholar
• Bracha D, Walls MT, Brangwynne CP. Probing and engineering liquid-phase organelles. Nat Biotechnol. 2019;37(12):1435–1445. doi:10.1038/s41587-019-0341-6
   PubMed Web of Science ®Google Scholar
• Lu B, Zou C, Yang M, et al. Pharmacological Inhibition of Core Regulatory Circuitry Liquid-liquid Phase Separation Suppresses Metastasis and Chemoresistance in Osteosarcoma. Adv Sci (Weinh). 2021;8(20):56.
   Google Scholar
• Liu J, Liu ZX, Li JJ, et al. The Macrophage-Associated LncRNA MALR Facilitates ILF3 Liquid-Liquid Phase Separation to Promote HIF1α Signaling in Esophageal Cancer. Cancer Res. 2023;83(9):1476–1489. doi:10.1158/0008-5472.CAN-22-1922
   PubMed Web of Science ®Google Scholar
• Zbinden A, Pérez-Berlanga M, De Rossi P, Polymenidou M. Phase Separation and Neurodegenerative Diseases: a Disturbance in the Force. Dev Cell. 2020;55(1):45–68. doi:10.1016/j.devcel.2020.09.014
   PubMed Web of Science ®Google Scholar
• Mehta S, Zhang J. Liquid-liquid phase separation drives cellular function and dysfunction in cancer. Nat Rev Cancer. 2022;22(4):239–252. doi:10.1038/s41568-022-00444-7
   PubMed Web of Science ®Google Scholar
• Tong X, Tang R, Xu J, et al. Liquid-liquid phase separation in tumor biology. Signal Transduct Target Ther. 2022;7(1):221. doi:10.1038/s41392-022-01076-x
   PubMed Web of Science ®Google Scholar
• Gusyatiner O, Hegi ME. Glioma epigenetics: from subclassification to novel treatment options. Semin Cancer Biol. 2018;51:50–58. doi:10.1016/j.semcancer.2017.11.010
   PubMed Web of Science ®Google Scholar
• Xu S, Tang L, Li X, Fan F, Liu Z. Immunotherapy for glioma: current management and future application. Cancer Lett. 2020;476:1–12. doi:10.1016/j.canlet.2020.02.002
   PubMed Web of Science ®Google Scholar
• Ostrom QT, Price M, Neff C, et al. CBTRUS Statistical Report: primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015-2019. Neuro Oncol. 2022;24(Suppl 5):v1–v95. doi:10.1093/neuonc/noac202
   PubMedGoogle Scholar
• Nicholson JG, Fine HA. Diffuse Glioma Heterogeneity and Its Therapeutic Implications. Cancer Discov. 2021;11(3):575–590. doi:10.1158/2159-8290.CD-20-1474
   PubMed Web of Science ®Google Scholar
• Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013;41(D1):D991–5. doi:10.1093/nar/gks1193
   PubMed Web of Science ®Google Scholar
• Goldman MJ, Craft B, Hastie M, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675–678. doi:10.1038/s41587-020-0546-8
   PubMed Web of Science ®Google Scholar
• Tran TO, Vo TH, Lam LHT, Le NQK. ALDH2 as a potential stem cell-related biomarker in lung adenocarcinoma: comprehensive multi-omics analysis. Comput Struct Biotechnol J. 2023;21:1921–1929. doi:10.1016/j.csbj.2023.02.045
   PubMed Web of Science ®Google Scholar
• Dang HH, Hdk T, Nguyen TTT, et al. Prospective role and immunotherapeutic targets of sideroflexin protein family in lung adenocarcinoma: evidence from bioinformatics validation. Funct Integr Genomics. 2022;22(5):1057–1072. doi:10.1007/s10142-022-00883-3
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47–e47. doi:10.1093/nar/gkv007
   PubMed Web of Science ®Google Scholar
• Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572–1573. doi:10.1093/bioinformatics/btq170
   PubMed Web of Science ®Google Scholar
• Wang W, Lu Z, Wang M, et al. The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma. Front Immunol. 2022;13:998236. doi:10.3389/fimmu.2022.998236
   PubMed Web of Science ®Google Scholar
• Li G, Wu Z, Gu J, et al. Metabolic Signature-Based Subtypes May Pave Novel Ways for Low-Grade Glioma Prognosis and Therapy. Front Cell Dev Biol. 2021;9:755776. doi:10.3389/fcell.2021.755776
   PubMedGoogle Scholar
• Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling Tumor Infiltrating Immune Cells with CIBERSORT. Methods Mol Biol. 2018;1711:243–259.
   PubMedGoogle Scholar
• Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–457. doi:10.1038/nmeth.3337
   PubMed Web of Science ®Google Scholar
• Cai D, Liu Z, Lippincott-Schwartz J. Biomolecular Condensates and Their Links to Cancer Progression. Trends Biochem Sci. 2021;46(7):535–549. doi:10.1016/j.tibs.2021.01.002
   PubMed Web of Science ®Google Scholar
• Xia S, Chen Z, Shen C, Fu TM. Higher-order assemblies in immune signaling: supramolecular complexes and phase separation. Protein Cell. 2021;12(9):680–694. doi:10.1007/s13238-021-00839-6
   PubMed Web of Science ®Google Scholar
• Meng F, Yu Z, Zhang D, et al. Induced phase separation of mutant NF2 imprisons the cGAS-STING machinery to abrogate antitumor immunity. Mol Cell. 2021;81(20):4147–4164.e7. doi:10.1016/j.molcel.2021.07.040
   PubMed Web of Science ®Google Scholar
• Ning L, Zhao G, Xie C, et al. Development and Validation of a Liquid-Liquid Phase Separation-Related Gene Signature as Prognostic Biomarker for Low-Grade Gliomas. Dis Markers. 2022;2022:1487165. doi:10.1155/2022/1487165
   PubMed Web of Science ®Google Scholar
• Zheng J, Wu Z, Qiu Y, Wang X, Jiang X. An integrative multi-omics analysis based on liquid-liquid phase separation delineates distinct subtypes of lower-grade glioma and identifies a prognostic signature. J Transl Med. 2022;20(1):55. doi:10.1186/s12967-022-03266-1
   PubMed Web of Science ®Google Scholar
• Zeng WJ, Lu C, Shi Y, et al. Initiation of stress granule assembly by rapid clustering of IGF2BP proteins upon osmotic shock. Biochim Biophys Acta Mol Cell Res. 2020;1867(10):118795. doi:10.1016/j.bbamcr.2020.118795
   PubMed Web of Science ®Google Scholar
• Gao Y, Jiang M, Guo F, et al. A novel lncRNA MTAR1 promotes cancer development through IGF2BPs mediated post-transcriptional regulation of c-MYC. Oncogene. 2022;41(42):4736–4753. doi:10.1038/s41388-022-02464-x
   PubMed Web of Science ®Google Scholar
• Han MZ, Xu R, Xu YY, et al. TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas. J Exp Clin Cancer Res. 2017;36(1):155. doi:10.1186/s13046-017-0619-9
   PubMed Web of Science ®Google Scholar
• Zhang X, Han J, Fan D, et al. Lysine-40 succinylation of TAGLN2 induces glioma angiogenesis and tumor growth through regulating TMSB4X. Cancer Gene Ther. 2023;30(1):172–181. doi:10.1038/s41417-022-00534-6
   PubMed Web of Science ®Google Scholar
• Ye T, Chen R, Zhou Y, et al. Salvianolic acid A (Sal A) suppresses malignant progression of glioma and enhances temozolomide (TMZ) sensitivity via repressing transgelin-2 (TAGLN2) mediated phosphatidylinositol-3-kinase (PI3K) / protein kinase B (Akt) pathway. Bioengineered. 2022;13(5):11646–11655. doi:10.1080/21655979.2022.2070963
   PubMed Web of Science ®Google Scholar
• Dias CM, Punetha J, Zheng C, et al. Homozygous Missense Variants in NTNG2, Encoding a Presynaptic Netrin-G2 Adhesion Protein, Lead to a Distinct Neurodevelopmental Disorder. Am J Hum Genet. 2019;105(5):1048–1056. doi:10.1016/j.ajhg.2019.09.025
   PubMed Web of Science ®Google Scholar
• Hao W, Yu M, Lin J, et al. The pan-cancer landscape of netrin family reveals potential oncogenic biomarkers. Sci Rep. 2020;10(1):5224. doi:10.1038/s41598-020-62117-5
   PubMed Web of Science ®Google Scholar
• Shao W, Zhao H, Zhang S, et al. A pan-cancer landscape of IGF2BPs and their association with prognosis, stemness and tumor immune microenvironment. Front Oncol. 2022;12:1049183. doi:10.3389/fonc.2022.1049183
   PubMed Web of Science ®Google Scholar
• Li H, Wang D, Yi B, et al. SUMOylation of IGF2BP2 promotes vasculogenic mimicry of glioma via regulating OIP5-AS1/miR-495-3p axis. Int J Bio Sci. 2021;17(11):2912–2930. doi:10.7150/ijbs.58035
   Google Scholar
• Han J, Yu X, Wang S, et al. IGF2BP2 Induces U251 Glioblastoma Cell Chemoresistance by Inhibiting FOXO1-Mediated PID1 Expression Through Stabilizing lncRNA DANCR. Front Cell Dev Biol. 2021;9:659228. doi:10.3389/fcell.2021.659228
   PubMed Web of Science ®Google Scholar
• Hinshaw DC, Shevde LA. The Tumor Microenvironment Innately Modulates Cancer Progression. Cancer Res. 2019;79(18):4557–4566. doi:10.1158/0008-5472.CAN-18-3962
   PubMed Web of Science ®Google Scholar
• Chen R, Wu W, Liu T, et al. Large-scale bulk RNA-seq analysis defines immune evasion mechanism related to mast cell in gliomas. Front Immunol. 2022;13:914001. doi:10.3389/fimmu.2022.914001
   PubMed Web of Science ®Google Scholar
• Attarha S, Roy A, Westermark B, Tchougounova E. Mast cells modulate proliferation, migration and stemness of glioma cells through downregulation of GSK3β expression and inhibition of STAT3 activation. Cell Signal. 2017;37:81–92. doi:10.1016/j.cellsig.2017.06.004
   PubMed Web of Science ®Google Scholar